Oxford BioTherapeutics
Belinda Cairns has extensive experience in histopathology, holding various titles such as Director of Histopathology, Principal Scientist, and Senior Scientist in companies such as Oxford BioTherapeutics, AbbVie, and Allergan Inc. Belinda has a Ph.D. in Neuroscience from the University of Oxford. Belinda's expertise includes leading IHC coordination, developing new methods for tissue evaluation, and managing experimental pathology departments to support research drug discovery and translational medicine.
This person is not in any offices
Oxford BioTherapeutics
Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.